bluebird bio Reports Third Quarter 2022 Financial Results and Highlights Operational ProgressBusiness Wire • 11/07/22
bluebird bio to Present at the 31st Annual Credit Suisse Healthcare ConferenceBusiness Wire • 11/02/22
Bluebird Bio (BLUE) May Report Negative Earnings: Know the Trend Ahead of Q3 ReleaseZacks Investment Research • 10/28/22
Bluebird (BLUE) Surges 15.7%: Is This an Indication of Further Gains?Zacks Investment Research • 09/22/22
Bluebird Bio Stock Soars on FDA Approval of Gene Therapy for Rare Neurological DiseaseBarrons • 09/19/22
bluebird bio Receives FDA Accelerated Approval for SKYSONA® Gene Therapy for Early, Active Cerebral Adrenoleukodystrophy (CALD)Business Wire • 09/17/22
Jason Cole, Chief Strategy and Financial Officer, to Depart bluebird bio This FallBusiness Wire • 09/12/22
10 Biotech Stocks Are Up 40% Or More This Year, Including Karuna, Axsome And OthersInvestors Business Daily • 08/29/22
These 5 Well-Known Stocks Trade Under $10 and Have Abundant Upside Potential24/7 Wall Street • 08/27/22